NK-611, with the CAS number 105655-99-0, is a chemical compound that has garnered attention in various research contexts, particularly in the field of medicinal chemistry. It is characterized as a selective serotonin reuptake inhibitor (SSRI), which suggests its potential use in the treatment of mood disorders such as depression and anxiety. The compound's structure typically features functional groups that facilitate its interaction with serotonin transporters, thereby influencing serotonin levels in the brain. NK-611 is noted for its pharmacological profile, which may include a favorable side effect profile compared to other SSRIs. Additionally, its solubility, stability, and bioavailability are important characteristics that influence its therapeutic efficacy. Research into NK-611 may also explore its mechanism of action, potential drug interactions, and long-term effects in clinical settings. As with any pharmaceutical compound, thorough investigation and clinical trials are essential to fully understand its safety and efficacy for human use.

NK-611

105655-99-0: NK-611, with the CAS number 105655-99-0, is a chemical compound that has garnered attention in various research contexts, particularly in the field of medicinal chemistry. It is characterized as a selective serotonin reuptake inhibitor (SSRI), which suggests its potential use in the treatment of mood disorders such as depression and anxiety. The compound's structure typically features functional groups that facilitate its interaction with serotonin transporters, thereby influencing serotonin levels in the brain. NK-611 is noted for its pharmacological profile, which may include a favorable side effect profile compared to other SSRIs. Additionally, its solubility, stability, and bioavailability are important characteristics that influence its therapeutic efficacy. Research into NK-611 may also explore its mechanism of action, potential drug interactions, and long-term effects in clinical settings. As with any pharmaceutical compound, thorough investigation and clinical trials are essential to fully understand its safety and efficacy for human use.

<p>NK-611 is a potent semisynthetic etoposide analogue that inhibits topoisomerase II and excels against various cancers in vitro.</p>

CAS 105655-99-0

NK-611

NK-611 free acid

Ref: TM-T71521